Insider Selling: John Amster Unloads 17,200 Shares of RPX Corp. Stock (RPXC)
RPX Corp. (NASDAQ:RPXC) CEO John Amster sold 17,200 shares of the stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $17.82, for a total value of $306,504.00. The sale was disclosed in a document filed with the SEC, which is available at this link.
RPXC has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of RPX Corp. from an “outperform” rating to a “neutral” rating in a research note to investors on Friday, August 2nd. They now have a $20.30 price target on the stock. Analysts at Lazard Capital Markets raised their price target on shares of RPX Corp. from $19.00 to $22.00 in a research note to investors on Thursday, August 1st. They now have a “buy” rating on the stock. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $19.83.
Shares of RPX Corp. (NASDAQ:RPXC) traded down 0.56% on Tuesday, hitting $17.79. 318,428 shares of the company’s stock traded hands. RPX Corp. has a 1-year low of $8.55 and a 1-year high of $19.88. The stock’s 50-day moving average is $17.14 and its 200-day moving average is $16.05. The company has a market cap of $927.9 million and a P/E ratio of 21.82.
RPX Corp. (NASDAQ:RPXC) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $0.26 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.23 by $0.03. The company had revenue of $57.50 million for the quarter, compared to the consensus estimate of $57.19 million. During the same quarter in the prior year, the company posted $0.29 earnings per share. The company’s quarterly revenue was up 4.2% on a year-over-year basis. Analysts expect that RPX Corp. will post $0.99 EPS for the current fiscal year.
RPX Corporation (NASDAQ:RPXC) provides patent risk management solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.